UK 05:57 Wednesday, 7 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I'm not really picking a fight with the short seller as he is basically a good chap but he has tweeted on Optibiotix (OPT) and Skinbiotherapeutics (SBTX) and he has, I think, got his facts wrong. For someone who may have an undeclared short position, that is perhaps unwise. I have swapped emails with at one CEO. If the other gets back to me I shall let you know but he is a bearded poltroon so many not.. I am also rowing with our in-house BB savant PL on NPVs ref Ariana (AAU). I cover Celadon (CEL) and revise my sordid price targets for Wishbone (WSBN) after news of a placing. I fear that the brothers in bromance, Richard Poulden and David Lenigas, are losing their ramping touch.
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
